Loopbaan van Clive Morris
Eerdere bekende functies van Clive Morris
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Inivata Ltd.
 Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom. | Directeur/Bestuurslid | 01-05-2016 | 30-06-2022 |
| Algemeen Directeur | 01-07-2018 | 18-06-2021 | |
| Hoofd Techniek/Wetenschap/O&O | 01-05-2016 | 01-07-2018 | |
| President | 18-06-2021 | 23-05-2022 | |
| NEOGENOMICS, INC. | Corporate Officer/Principal | - | 30-06-2022 |
| CorpHQ, Inc. | Corporate Officer/Principal | - | 06-08-2007 |
| ASTRAZENECA PLC | Public Communications Contact | 06-01-2011 | - |
Opleiding van Clive Morris
| The Royal College of Surgeons of England | Doctorate Degree |
Statistieken
Internationaal
| Verenigd Koninkrijk | 4 |
| Verenigde Staten | 3 |
Operationeel
| Corporate Officer/Principal | 2 |
| Public Communications Contact | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Communications | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| NEOGENOMICS, INC. | Health Services |
| Bedrijven in privébezit | 2 |
|---|---|
| CorpHQ, Inc. | Communications |
Inivata Ltd.
Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom. | Technology Services |
- Beurs
- Insiders
- Clive Morris
- Ervaring
